entity

T2DM

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about T2DM: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

9Connections
0Hypotheses
0Analyses
8Outgoing
1Incoming

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

nct06365190-rtms-pd

clinical_trial · 3270 words

Digital Therapeutics for Parkinson's Disease

technology · 3124 words

Alpha-Synuclein Seed Kinetic Staging in Parkinson's Disease

biomarker · 3114 words

Arcuate Nucleus POMC Neurons

cell · 3046 words

Outgoing (8)

TargetRelationTypeStr
Sarcopeniaassociated_withphenotype0.95
Cognitive Declineassociated_withphenotype0.95
Sarcopeniacausesphenotype0.95
Alzheimer'S Diseaserisk_factor_fordisease0.95
INSULIN_RESISTANCEcausesphenotype0.72

Incoming (1)

SourceRelationTypeStr
PDassociated_withdisease0.64

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found